The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Indications/Uses
INVEGA TRINZA (paliperidone palmitate), a 3-month injection, is indicated for the treatment of schizophrenia in patients after they have been adequately treated with INVEGA SUSTENNA (1-month paliperidone palmitate extended-release injectable suspension) for at least four months (see Schizophrenia under Dosage & Administration and Pharmacology: Pharmacodynamics: Clinical Studies under Actions).
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign Out
